Feedback from the Sixth International AIDS Conference, San Francisco 1990.
出版信息
Genitourin Med. 1991 Apr;67(2):162-71. doi: 10.1136/sti.67.2.162.
Abstract
摘要
相似文献
1
Feedback from the Sixth International AIDS Conference, San Francisco 1990.1990年于旧金山召开的第六届国际艾滋病大会的反馈意见。
Genitourin Med. 1991 Apr;67(2):162-71. doi: 10.1136/sti.67.2.162.
2
[AIDS and HIV infection--1989].[艾滋病与艾滋病毒感染——1989年]
Przegl Epidemiol. 1991;45(1-2):127-35.
3
Fifth International Conference on the acquired immunodeficiency syndrome.
Med J Aust. 1990 Feb 19;152(4):204-11, 214. doi: 10.5694/j.1326-5377.1990.tb125151.x.
4
AIDS and HIV-1 infection in the United Kingdom: monthly report.英国的艾滋病与HIV-1感染：月度报告。
Commun Dis Rep CDR Wkly. 1996 Apr 19;6(16):141-4.
5
The natural history of HIV and AIDS in women.
AIDS. 1991 Nov;5(11):1283-92. doi: 10.1097/00002030-199111000-00001.
6
Prophylactic zidovudine after occupational exposure to the human immunodeficiency virus: an interim analysis.
J Infect Dis. 1989 Aug;160(2):321-7. doi: 10.1093/infdis/160.2.321.
7
HIV/AIDS estimates and the quest for universal access.艾滋病毒/艾滋病的估计数与普及治疗的追求。
Lancet. 2008 Jun 21;371(9630):2068-70. doi: 10.1016/S0140-6736(08)60732-1.
8
[Epidemic of AIDS in Mexico. Global analysis 1981-1996].
Gac Med Mex. 1996 Sep-Oct;132(5):545-50.
9
Projections of AIDS morbidity and mortality in San Francisco.旧金山艾滋病发病率和死亡率预测。
JAMA. 1990 Mar 16;263(11):1497-501.
10
The acquired immunodeficiency syndrome epidemic: issues for health care professionals. Ninth annual National Foundation for Infectious Diseases lecture.
Am J Infect Control. 1986 Dec;14(6):272-9. doi: 10.1016/0196-6553(86)90039-8.
本文引用的文献
1
Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: results from the multicenter AIDS Cohort Study.在其他方面健康的HIV-1感染者中神经和神经心理异常的低患病率：多中心艾滋病队列研究结果
Ann Neurol. 1989 Nov;26(5):601-11. doi: 10.1002/ana.410260504.
2
Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).HIV-1逆转录酶中的多个突变赋予对齐多夫定（AZT）的高水平耐药性。
Science. 1989 Dec 1;246(4934):1155-8. doi: 10.1126/science.2479983.
3
HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.在长期治疗期间分离出的对齐多夫定（AZT）敏感性降低的HIV。
Science. 1989 Mar 31;243(4899):1731-4. doi: 10.1126/science.2467383.
4
HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. The Multicenter AIDS Cohort Study.人类免疫缺陷病毒1型感染：无症状期无认知功能衰退证据。多中心艾滋病队列研究。
Neurology. 1990 Feb;40(2):204-8. doi: 10.1212/wnl.40.2.204.
5
Fluconazole, a new antifungal agent.氟康唑，一种新型抗真菌剂。
Ann Intern Med. 1990 Aug 1;113(3):177-9. doi: 10.7326/0003-4819-113-3-177.
6
A pilot study of low-dose zidovudine in human immunodeficiency virus infection.低剂量齐多夫定治疗人类免疫缺陷病毒感染的初步研究。
N Engl J Med. 1990 Oct 11;323(15):1015-21. doi: 10.1056/NEJM199010113231502.
7
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
N Engl J Med. 1990 Oct 11;323(15):1009-14. doi: 10.1056/NEJM199010113231501.
8
Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial.雾化喷他脒预防卡氏肺孢子虫肺炎。旧金山社区预防试验。
N Engl J Med. 1990 Sep 20;323(12):769-75. doi: 10.1056/NEJM199009203231201.
9
Monitoring of lymphocyte subpopulation changes in the assessment of HIV infection.在评估HIV感染中监测淋巴细胞亚群变化。
Genitourin Med. 1990 Jun;66(3):133-7. doi: 10.1136/sti.66.3.133.
10
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.齐多夫定（AZT）治疗轻度症状的1型人类免疫缺陷病毒（HIV）感染患者的安全性和有效性。一项双盲、安慰剂对照试验。艾滋病临床试验组。
Ann Intern Med. 1990 May 15;112(10):727-37. doi: 10.7326/0003-4819-112-10-727.
Zotero 插件